Aug 09, 2023 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2023 second-quarter conference call. (Operator Instructions)
Participants of today's call are advised that the audio of this conference call is being broadcast live over the internet and is also being recorded for playback purposes. A webcast call -- a webcast replay of the call will be available approximately one hour after the end of the call through November 9, 2023.
At this time, I would like to turn the conference over to Miranda Peto of BioCardia Investor Relations. Please go ahead, Miranda.
Miranda Peto - BioCardia, Inc. - IR
Thank you very much. Good afternoon and thank you for participating in today's conference call. Joining me from BioCardia's leadership team are Peter Altman, PhD, President and CEO; and David McClung, the Company's Chief Financial Officer.
During this call, management will be making forward-looking statements including statements that address BioCardia's expectations for future performance and operational results
Q2 2023 BioCardia Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
